IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,589,263 | -10.5% | 476,559 | -1.1% | 0.04% | -7.0% |
Q2 2023 | $5,128,352 | -4.1% | 481,988 | -5.1% | 0.04% | +95.5% |
Q1 2023 | $5,345,234 | +150.2% | 508,102 | +146.4% | 0.02% | +10.0% |
Q3 2022 | $2,136,000 | -14.2% | 206,221 | -4.5% | 0.02% | -9.1% |
Q2 2022 | $2,489,000 | -13.1% | 215,861 | -5.2% | 0.02% | +4.8% |
Q1 2022 | $2,865,000 | +14.4% | 227,710 | +6.0% | 0.02% | +16.7% |
Q4 2021 | $2,504,000 | -10.7% | 214,754 | 0.0% | 0.02% | -14.3% |
Q3 2021 | $2,805,000 | – | 214,754 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
13D Management LLC | 600,431 | $6,923,000 | 3.06% |
BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |